Also Read | What 2020 did to India’s inequality"In a meeting conducted by [the] Registration Board of Drap today January 18, 2021, another vaccine manufactured by China National Pharmaceutical Group (Sinopharm) has also been given EUA (emergency use authorisation)," a spokesperson for the regulatory body said in a statement.Both the Oxford and Sinopharm vaccines were evaluated for their safety and quality and granted EUA "with certain conditions", the statement added."This authorisation will be reviewed on a quarterly basis keeping in view further data regarding safety, efficacy and quality," it said.Sinopharm is developed by the Beijing Institute of Biological Products, a state-owned subsidiary conglomerate.